Professor Garry Nolan Interview Feb. 6th. 2022 Were we are in the UFO story . . . .

 

 

Ross Coulthart interview with Professor Gary Nolan June 22^nd. 2022

Link:

https://www.youtube.com/watch?v=XR0JtbuLhPo

"What Is "IT" . . . . Garry Nolan considers UFOs . . .

I wish I knew, I have talked to people on the inside and their is very little agreement to what "It” is . . .

 

What ever “It” is, it’s so far advanced from us that it beggars our understanding. That “it” is beyond our full comprehension.

They seem to affect our culture overall "over time" with their interactions in general .  . . .  It's much,  much more complicated than we think . . . .

We are often left with more question than the data left from an encounters with “them” can tell us . . .

 

It is not Human . . . .   

It is intelligent and acts in an intelligent manner.

 

There is a uniform pattern to the UFO stories, they match each other over the years.

This intelligence even has a sense of humor in some cases when relating to “us”.

It's been here a long time:  over 1000's of years . . . . longer than we have been civilized . . .

 

 

Link: Lex Fridman    Feb.6th.  2022   interview

https://www.youtube.com/watch?v=uTCc2-1tbBQ&t=1065sk:

 

Professor Garry Nolan Interview (Ross Coulthart Interview)

Link:

https://www.youtube.com/watch?v=XR0JtbuLhPo&t=1051s

 

In an interview in June of 2022, Professor Garry Nolan Stated:

Some Big news is coming out. 

The recent events from 2017 till now 2023 with the 12 whistle blowers coming out, Garry feels the news will break within 2 years in a 2022 quote.

 

Nolan: It's not what we going to "do" about the UFO phenonium.

It needs to studied, and in my heart, I have hope that Government will releases all UFO materials to be studied. It wont go to the public, but controlled.

I am excited to find out what we can learn from this in our future.

 

The ability to hover, instant acceleration to 5000 miles per hour. Way past our technology . . . .

Garry Nolan is one of the smartest men on the planet. 

At the bottom of this page is Garry Nolan's list of Medical Patents . . .

 

 

The 1st UFO Material Isotopic Test Published

Publicly released in Nov. 2023

A UFO dropped some waste metal in 2 cases. The samples are from a blob of metal on the ground. Molten metal was left behind from a UFO overhead. This is well documented.

Garry Nolan has the best equipment for the job.

 

Nolan: “A reasonable subset of them had claimed to have seen UAPs and some claimed to be close to things that got them sick.”

Ultimately, his team learned the people, who they originally thought were damaged, had an “over-connection of neurons between the head of the caudate and the putamen.”

The number of people that had this “over-connection” led to the open question: “Did coming in contact with whatever it was cause it or not?”

Sensitive to observing UFOs have this “over-connection of neurons between the head of the caudate and the putamen.”

 

Below a 3d rotateing view at:

https://upload.wikimedia.org/wikipedia/commons/4/41/Caudate_nucleus.gif

Dr. Nolan:

There is a bundle of nerves at the head of the Caudate and the Putamen.

The Basil Ganglia, that is important in reasoning.

Formulating a goal, and a subset or lists of what you will need to do to accomplish this one thought process.  Completing the process of achieving goals in the brain translates into actions by "us" in the physical world.

It’s an Executive Function of the brain to accomplish goals, intuition, and perception of the physical world.

There is a density of these nerves 1 in 200 have this.

 

 

Sample Of Tara HZ wave Tech . . . .

Do You Have a Current MRI on File ?

 

The number of people that had this “over-connection” led to the open question: “Did coming in contact with whatever it was cause it or not?”

It's Inherited passed down family lines. 

In Nolan's family his Mother, his brother, and sister, have this increased amount of nerve connectivity found by MRI . . . .

 

It's a dominant trait, when two smart people are attracted to smart people. They marry and have children. Their children marry smart people and pass this connectivity down the line. It can increase intelligence over a long, long, period of time. This has been proven genetically. 

 

This is what you get,  "Extra Connectivity" in this area of the brain . . . .

 

The basal ganglia control body movements. This is a long-standing concept that has been confirmed repeatedly by animal experiments and human movement disorders.

Experimental lesions of various parts of the basal ganglia impair the initiation, execution, and inhibition of spontaneous and planned body movements Pathological lesions of the human basal ganglia are associated with a variety of movement disorders, including involuntary movements.

A number of neurodegenerative diseases involve the basal ganglia. The most common among them is Parkinson’s disease, which is typically associated with tremor, bradykinesia (akinesia), and rigidity).

Overall, basal ganglia dysfunctions lead to a remarkable set of movement disorders, suggesting that the basal ganglia contain multiple mechanisms for controlling body movements.

However, animals and humans with basal ganglia dysfunctions show deficits that may not simply be classified as movement disorders.

For example, animals with large lesions in the striatum may ignore a moving object or obsessively follow it Patients with Parkinson’s disease may have difficulty in performing two movements simultaneously or in learning of probabilistic classification Dopamine deficiency in the striatum leads to severe contralateral hemi-neglect in monkeys.

Humans with restricted lesions in the caudate nucleus or the globus pallidus may be unable to initiate everyday behaviors spontaneously.

Patients with Parkinson’s disease may be less motivated in achieving goals and may also show symptoms of depression.

 

These observations, as well as many others not described here,

suggest that the basal ganglia are involved in many mental processes:

including motor

sensory

learning

memory

cognitive executive decision-making,

motivational

emotional functions

 

 

 

Current Patents in Medicine as of 2023:

Professor Garry Nolan . . . .

Patents

• Garry Nolan. "United States Patent 1,166,795,6. Methods of identifying multiple epitopes in cells.", Jun 6, 2023

• Garry Nolan. "United States Patent 1,163,475,2. Kit for split-pool barcoding target molecules that are in or on cells or cell organelles.", Apr 25, 2023

• Garry Nolan. "United States Patent 1,163,475,2. Kit for split-pool barcoding target molecules that are in or on cells or cell organelles.", Apr 25, 2023

• Garry Nolan. "United States Patent 1,163,475,3 On-slide staining by primer extension.", Apr 25, 2023

• Garry Nolan. "United States Patent 1,156,627,8. Methods of identifying multiple epitopes in cells.", Jan 31, 2023

• Garry Nolan. "United States Patent 1,156,058,5. Methods of identifying multiple epitopes in cells.", Jan 24, 2023

• Garry Nolan. "United States Patent 1,129,977,0 On-slide staining by primer extension.", Apr 12, 2022

• Garry Nolan. "United States Patent 1,121,479,4. Increasing dynamic range for identifying multiple epitopes in cells.", Jan 4, 2022

• Garry Nolan. "United States Patent 1,116,835,0 Highly multiplexed fluorescent imaging.", Nov 9, 2021

• Garry Nolan. "United States Patent 1,100,860,8 Multiplexed single molecule RNA visualization with a two-probe proximity ligation system", May 18, 2021

• Garry Nolan. "United States Patent 1,0995,362 Methods of identifying multiple epitopes in cells.", May 4, 2021

• Garry Nolan. "United States Patent 1,098,226,3 On-slide staining by primer extension.", Apr 20, 2021

• Garry Nolan. "United States Patent 1,083,279,5. Compressed sensing for simultaneous measurement of multiple different biological molecule types in a sample", Nov 10, 2020

• Garry Nolan. "United States Patent 1,068,968,7. Detection of target nucleic acids in a cellular sample", Jun 23, 2020

• Garry Nolan. "United States Patent 1,037,069,8. Highly-multiplexed fluorescent imaging.", Aug 6, 2019

• Garry Nolan. "United States Patent 1,028,980,2. Spanning-tree progression analysis of density-normalized events", May 14, 2019

• Garry Nolan. "United States Patent 1,0267,802 Methods of prognosis and diagnosis of ovarian cancer.", Apr 23, 2019

• Garry Nolan. "United States Patent 1,011,400,4. Single cell analysis using secondary ion mass spectrometry.", Oct 30, 2018

• Garry Nolan. "United States Patent 1,004,194,9. Multiplexed imaging of tissues using mass tags and secondary ion mass spectrometry.", Aug 7, 2018

• Garry Nolan. "United States Patent 1,001,780,8. On-slide staining by primer extension.", Jul 10, 2018

• Garry Nolan. "United States Patent 1,000,6082. On-slide straining by primer extension.", Jun 26, 2018

• Garry Nolan. "United States Patent 1,000,079,6 On-slide staining by primer extension.", Jun 19, 2018

• Garry Nolan. "United States Patent 9,909,167 On-slide staining by primer extension.", Mar 6, 2018

• Garry Nolan. "United States Patent 9,783,841 Detection of target nucleic acids in a cellular sample.", Oct 10, 2017

• Garry Nolan. "United States Patent 9,766,224. Single cell analysis using secondary ion mass spectrometry.", Sep 19, 2017

• Garry Nolan. "United States Patent 9,739,765. Metal-based covalent viability reagent for single cell analysis", Aug 22, 2017

• Garry Nolan. "United States Patent 9,312,111. Apparatus and method for sub-micrometer elemental image analysis by mass spectrometry", Apr 12, 2016

• Garry Nolan. "United States Patent 8,945,846 Mutations in the LNK gene in patients with myeloproliferative neoplasms and other hematolymphoid malignancies.", Feb 3, 2015

• Garry Nolan. "United States Patent 8,778,620 Methods for diagnosis, prognosis and methods of treatment.", Jul 15, 2014

• Garry Nolan. "United States Patent 9,500,655 Methods for diagnosis, prognosis and methods of treatment.", May 16, 2014

• Garry Nolan. "United States Patent 1,017,4310 Increasing dynamic range for identifying multiple epitopes in cells.", Aug 8, 2013

• Garry Nolan. "United States Patent 8,227,202 Methods for diagnosis, prognosis and methods of treatment", Jul 24, 2012

• Garry Nolan. "United States Patent 7,939,278 Methods and compositions for risk stratification.", May 10, 2011

• Garry Nolan. "United States Patent 7,695,924 Methods and compositions for detecting receptor-ligand interactions in single cells", Apr 13, 2010

• Garry Nolan. "United States Patent 7,695,926 Methods and compositions for detecting receptor-ligand interactions in single cells.", Apr 13, 2010

• Garry Nolan. "United States Patent 8,309,306 Detection composition", Nov 12, 2009

• Garry Nolan. "United States Patent 7,563,584 Methods and compositions for detecting the activation state of multiple proteins in single cells", Jul 21, 2009

• Garry Nolan. "United States Patent 7,393,656 Methods and compositions for risk stratification.", Jul 1, 2008

• Garry Nolan. "United States Patent 7,381,535 Methods and compositions for detecting receptor-ligand interactions in single cells", Jun 3, 2008

• Garry Nolan. "United States Patent 7,332,356 Fluorescent dye binding peptides", Feb 19, 2008

• Garry Nolan. "United States Patent 8,003,312 Multiplex cellular assays using detectable cell barcodes.", Feb 14, 2008

• Garry Nolan. "United States Patent 6,969,584 Combinatorial enzymatic complexes. Garry P. Nolan and Payan; Donald", Nov 29, 2005

• Garry Nolan. "United States Patent 6,833,245 Methods for screening for transdominant effector peptides and RNA molecules", Dec 21, 2004

• Garry Nolan. "United States Patent 6,747,135 Peptide and RNA Affinity-based Fluorophores.", Jun 8, 2004

• Garry Nolan. "United States Patent 6,737,241 Methods for screening for transdominant intracellular effector peptides and RNA molecules", May 18, 2004

• Garry Nolan. "United States Patent 6,727,350 Toso, a cell-surface regulator of Fas-induced apoptosis.", Apr 27, 2004

• Garry Nolan. "United States Patent 6,455,247 Methods for screening for transdominant effector peptides and RNA molecules.", Sep 24, 2002

• Garry Nolan. "United States Patent 6,365,344 Methods for screening for transdominant effector peptides and RNA molecules.", Apr 2, 2002

• Garry Nolan. "United States Patent 6,153,380 Methods for screening for transdominant intracellular effector peptides and RNA molecules", Nov 28, 2000

• Garry Nolan. "United States Patent 5,830,725 Rapid, stable high-titer production of recombinant retrovirus", Nov 3, 1998

• Garry Nolan. "United States Patent 5,070,012 Monitoring of cells and trans-activating transcription elements.", Dec 3, 1991